[1]
|
Volanis, D., Kadiyska, T., Galanis, A., Delakas, D., Logotheti, S. and Zoumpourlis, V. (2010) Environmental factors and genetic susceptibility promote urinary bladder cancer. Toxicology Letters, 193, 131-137.
doi:10.1016/j.toxlet.2009.12.018
|
[2]
|
Zeegers, M.P., Goldbohm, R.A. and van den Brandt, P.A. (2002) A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands). Cancer Causes and Control, 13, 83-90.
doi:10.1023/A:1013954932343
|
[3]
|
Samanic, C., et al. (2006) Smoking and bladder cancer in Spain: Effects of tobacco type, timing, environmental tobacco smoke, and gender. Cancer Epidemiology, Biomarkers & Prevention, 15, 1348-1354.
doi:10.1158/1055-9965.EPI-06-0021
|
[4]
|
International Agency for Research on Cancer (1986) IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans: Tobacco smoking. World Health Organization, Lyon.
|
[5]
|
Strope, S.A. and Montie, J.E. (2008) The causal role of cigarette smoking in bladder cancer initiation and progression, and the role of urologists in smoking cessation. Journal of Urology, 180, 31-37.
doi:10.1016/j.juro.2008.03.045
|
[6]
|
Wu, C.C., et al. (2012) Joint Effect of Arsenic Methylation Profile and NNK Metabolites on Urothelial Carcinoma. Journal of Urology, 188, 1701-1705.
doi:10.1016/j.juro.2012.07.025
|
[7]
|
Kalble, T. (2001) Etiopathology, risk factors, environmental influences and epidemiology of bladder cancer. Urologe A, 40, 447-450.
|
[8]
|
Pelucchi, C., Bosetti, C., Negri, E., Malvezzi, M. and La Vecchia, C. (2006) Mechanisms of disease: The epidemicology of bladder cancer. Nature Clinical Practice Urology, 3, 327-340. doi:10.1038/ncpuro0510
|
[9]
|
Vineis, P. and Porta, M. (1996) Causal thinking, biomarkers, and mechanisms of carcinogenesis. Journal of Clinical Epidemiology, 49, 951-956.
doi:10.1016/0895-4356(96)00118-7
|
[10]
|
Di Pietro, G., Magno, L.A. and Rios-Santos, F. (2010) Glutathione Stransferases: An overview in cancer research. Expert Opinion on Drug Meta-bolism & Toxicology, 6, 153-170. doi:10.1517/17425250903427980
|
[11]
|
Simic, T., Savic-Radojevic, A., Pljesa-Ercegovac, M., Matic, M. and Mimic-Oka, J. (2009) Glutathione Stransferases in kidney and urinary bladder tumors. Nature Reviews Urology, 6, 281-289. doi:10.1038/nrurol.2009.49
|
[12]
|
Landi, S. (2000) Mammalian class theta GST and differential susceptibility to carcinogens: A review. Mutation Research, 463, 247-283.
doi:10.1016/S1383-5742(00)00050-8
|
[13]
|
Whitbread, A.K., et al. (2005) Characterization of the omega class of glutathione transferases. Methods in Enzymology, 401, 78-99.
doi:10.1016/S0076-6879(05)01005-0
|
[14]
|
Schmuck, E.M., et al. (2005) Characterization of the monomethylarsonate reductase and dehydroascorbate reductase activities of Omega class glutathione transferase variants: Implications for arsenic metabolism and the age-at-onset of Alzheimer’s and Parkinson’s diseases. Pharmacogenetics and Genomics, 15, 493-501.
doi:10.1097/01.fpc.0000165725.81559.e3
|
[15]
|
Tanaka-Kagawa, T., et al. (2003) Functional characterization of two variant human GSTO 1-1s (Ala140Asp and Thr217Asn). Biochemical and Biophysical Research Communications, 301, 516-520.
doi:10.1016/S0006-291X(02)03066-8
|
[16]
|
Whitbread, A.K., Tetlow, N., Eyre, H.J., Sutherland, G.R. and Board, P.G. (2003) Characterization of the human Omega class glutathione transferase genes and associated polymorphisms. Pharmacogenetics, 13, 131-144.
doi:10.1097/01.fpc.0000054062.98065.6e
|
[17]
|
Xu, Y., et al. (2009) Lack of association of glutathione-Stransferase omega 1 (A140D) and omega 2 (N142D) gene polymorphisms with urinary arsenic profile and oxidative stress status in arsenic-exposed population. Mutation Research, 679, 44-49. doi:10.1016/j.mrgentox.2009.07.008
|
[18]
|
Schlecht, N.F., et al. (1999) Interaction between tobacco and alcohol consumption and the risk of cancers of the upper aerodigestive tract in Brazil. American Journal of Epidemiology, 150, 1129-1137.
doi:cgi/content/short/150/11/1129
|
[19]
|
Marahatta, S.B., et al. (2006) Polymorphism of glutathione Stransferase omega gene and risk of cancer. Cancer Letters, 236, 276-281.
doi:10.1016/j.canlet.2005.05.020
|
[20]
|
Granja, F., Morari, E.C., Assump??o, L.V. and Ward, L.S. (2005) GSTO polymorphism analysis in thyroid nodules suggest that GSTO1 variants do not influence the risk for malignancy. European Journal of Cancer Prevention, 14, 277-280. doi:10.1097/00008469-200506000-00013
|
[21]
|
Board, P.G. (2011) The omega-class glutathione transferases: Structure, function, and genetics. Drug Metabolism Reviews, 43, 226-235.
doi:10.3109/03602532.2011.561353
|
[22]
|
Mukherjee, B. et al. (2006) Glutathione Stransferase omega 1 and omega 2 pharmacogenomics. Drug Metabolism and Disposition, 34, 1237-1246.
doi:10.1124/dmd.106.009613
|
[23]
|
Board, P.G. and Anders, M.W. (2007) Glutathione transferase omega 1 catalyzes the reduction of S(phenacyl) glutathiones to acetophenones. Chemical Research in Toxicology, 20, 149-154. doi:10.1021/tx600305y
|
[24]
|
Sanguansin, S., Petmitr, S., O-Charoenrat, P. and Pongstaporn, W. (2012) Association of glutathione Stransferase omega gene polymorphisms with progression of head and neck cancer. Molecular Biology Reports, 39, 10915-10920. doi:10.1007/s11033-012-1991-3
|
[25]
|
Yanbaeva, D.G., Wouters, E.F., Dentener, M.A., Spruit, M.A. and Reynaert, N.L. (2009) Association of glutathione-Stransferase omega haplotypes with susceptibility to chronic obstructive pulmonary disease. Free Radcal Research, 43, 738-743.
doi:10.1080/10715760903038440
|